Anthem Biosciences Limited (BOM:544449)
773.45
+3.30 (0.43%)
At close: Apr 28, 2026
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 434.85 billion as of April 29, 2026.
Market Cap
434.85B
Enterprise Value
425.64B
Revenue
20.02B
Ranking
n/a
PE Ratio
89.72
Stock Price
773.45
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 434.85B, an increase of 6.02%. That is a compound annual growth rate of 7.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 434.85B | 18.85% |
| Dec 31, 2025 | 365.89B | -10.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mphasis | 415.34B |
| Authum Investment & Infrastructure | 414.38B |
| NLC India | 414.19B |
| GlaxoSmithKline Pharmaceuticals | 418.95B |
| Balkrishna Industries | 431.33B |
| J.K. Cement | 431.79B |
| United Breweries | 390.46B |
| KEI Industries | 460.19B |